5mg Mounjaro Not Working — What's Actually Happening and What Comes Next

Step 1, Understand what the 5mg dose is actually for

Tirzepatide's licensed schedule opens at 2.5mg for a month, then 5mg for a further four weeks, before any move toward the 7.5mg dose and above. Neither of those first two steps is intended to be the dose that drives weight loss. Their purpose is physiological adjustment: slowing gastric emptying gradually, letting your gut get used to a dual GIP and GLP-1 receptor agonist before the dose reaches a level where appetite suppression becomes meaningful for most people.

That framing matters because "not working" at 5mg is not a signal that tirzepatide will not work for you. It is more often a signal that you are where the schedule expects you to be. The pattern at tirzepatide 5mg is consistent: appetite reduction is modest, weight loss is typically small or negligible, and most patients who later reach 10mg or 15mg look back on the early weeks as unremarkable.

The NHS medicines page for tirzepatide on NHS.uk describes the dose escalation schedule clearly and is worth reading alongside your Patient Information Leaflet. The licensed UK strengths run from 2.5mg up to 15mg, and the evidence from the SURMOUNT clinical programme shows that meaningful average weight reductions are concentrated at the higher doses.

Step 2, Check whether enough time has passed at this dose

Four weeks is the standard minimum at each dose. If it feels as though 5mg Mounjaro is not working but you have only been on it for two or three weeks, the timeline itself may be the answer. Tirzepatide takes time to reach steady state in the body, and weight loss can lag behind appetite changes by several weeks on top of that.

Keep a simple log: weekly weight at the same time of day, and a rough sense of whether portion sizes or hunger levels have shifted even slightly. Absence of dramatic scale movement in the first month at 5mg is normal. Small changes in appetite or fullness, even ones you barely notice day to day, are a sign the medicine is beginning to act.

If you have completed four weeks at 5mg with tolerable side effects and almost no appetite change, the next conversation is about titration. That conversation belongs with your prescriber. Some people also find the 2.5mg starter dose uneventful, which can set an expectation that nothing will shift, the trajectory often changes at 7.5mg and above.

Step 3, Recognise what titration is actually about

Moving from 5mg to 7.5mg is not an admission of failure. It is the designed next step for people who have tolerated the lower doses without significant adverse effects. The prescriber's assessment at this stage looks at how you have responded to 5mg: nausea, vomiting, other gastrointestinal symptoms, and whether any of those effects have settled. If they have, and four weeks are up, titration is usually the recommendation.

People who later find 7.5mg Mounjaro not working tend to follow the same pattern: results accumulate at higher doses. NICE's appraisal of tirzepatide, TA1026, evaluated the full SURMOUNT evidence base and recommends the medicine for eligible adults with obesity, the trial data that informed that decision came predominantly from participants maintained at 10mg and 15mg.

The weight loss at 15mg in SURMOUNT-1 averaged around 20–21% of body weight over 72 weeks. That figure is a long way from where 5mg sits. Even at the highest licensed dose, results vary and the prescription context matters. Tirzepatide is not a quick fix at any dose, but the clinical picture at 5mg is simply too early to draw conclusions.

Step 4, What to actually do if you feel stuck

Contact your prescriber before changing anything. Do not skip doses, double up, or try to move yourself to the next strength. If you are on a 5mg Mounjaro pen and genuinely feel no effect after four weeks with minimal side effects, put that clearly to your prescribing team. Give them your weight log and a description of any appetite change, however small.

It is also worth being honest about the lifestyle context. Tirzepatide works alongside a reduced-calorie diet and increased physical activity; if that scaffolding has not been in place, the medicine's effect will be blunted. That is not a judgement, it is a pharmacology point. The dose and the lifestyle work together.

If cost or access is part of what is making this feel complicated, our Mounjaro cost page sets out what is included in a private prescription and how pricing typically works. And if you are thinking about what an appropriate longer-term maintenance strategy looks like, the evidence on lower-dose Mounjaro for maintenance is worth reviewing with a prescriber once you have reached your target. For now, the single most useful action is speaking to a clinician about titration. Speak to our prescribers at the consultation page if you do not currently have prescriber support in place.